Sequana Medical Announces First Patient Enrolled in North American alfapump® Pivotal Study (POSEIDON)

    NEXT STORY
    Sequana Medical Announces 2019 Half Year Results and Year-to-date Business Update
    PREV STORY
    ALBERTA BOEHRINGER INGELHEIM COLLABORATION FUND ANNOUNCES NEW RESEARCH FOR PATIENTS LIVING WITH RESPIRATORY DISEASE
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    VBL Therapeutics Announces First Quarter 2017 Financial Results

    TEL AVIV, Israel, May 15, 2017 (GLOBE NEWSWIRE) -- VBL Therapeutics (NASDAQ:VBLT), a clinical-stage ...

    author_avatar
    NASDAQ Market News

    Chinese Precision Medicine Market Set to Witness a Robust CAGR of 12.82% Over 2019-2029 – Cloud-Based Genomics Set to Be the Cornerstone of China’s Precision Medicine Revolution

    author_avatar
    NASDAQ Market News

    Malvern Federal Charitable Foundation Awards Grants to Local Charitable Nonprofit Organizations

    PAOLI, Pa., Oct. 05, 2017 (GLOBE NEWSWIRE) -- Malvern Federal Charitable Foundation is pleased ...

    author_avatar
    NASDAQ Market News